Literature DB >> 20367931

[Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].

Jin Yu1, Ruo-yu Li, Lu-juan Gao, Qiao-yun Lu, Xiao-hong Wang.   

Abstract

OBJECTIVE: To evaluate the performance of the galactomannan enzyme immunoassay (GM test) and (1,3)beta-D-glucan assay (G test) for the diagnosis of invasive fungal infection (IFI).
METHODS: A retrospective study was performed in 115 hospitalized patients at Peking University First Hospital who were at risk of IFI. Patients were diagnosed as IFI according to revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated at different cutoff values for two assays respectively. Two tests were combined to evaluate the changes of sensitivity, specificity, PPV and NPV.
RESULTS: The best sensitivity (54.5%, 63.6%) and specificity (77.9%, 69.2%) were obtained with the cutoff values of 0.5 and 20 x 10(3) pg/L in GM test and G test respectively. The PPV were 20.7% and 17.9%, and the NPV were 94.2% and 94.7% respectively. The sensitivity increased to 90.9% and the specificity was 52.9% after a combined utility of two tests.
CONCLUSION: The GM test and G tests are both useful in diagnosis of IFI with the cutoff values of 0.5 and 20 x 10(3) pg/L. A better sensitivity is acquired if there is a combined utility of two tests.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367931

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  5 in total

Review 1.  Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.

Authors:  Akira Onishi; Daisuke Sugiyama; Yoshinori Kogata; Jun Saegusa; Takeshi Sugimoto; Seiji Kawano; Akio Morinobu; Kunihiro Nishimura; Shunichi Kumagai
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.

Authors:  Karl Dichtl; Ulrich Seybold; Johannes Wagener
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

3.  Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.

Authors:  Wei-Jie Li; Ya-Ling Guo; Tang-Juan Liu; Ke Wang; Jin-Liang Kong
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 4.  Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Authors:  Mariska M G Leeflang; Yvette J Debets-Ossenkopp; Junfeng Wang; Caroline E Visser; Rob J P M Scholten; Lotty Hooft; Henk A Bijlmer; Johannes B Reitsma; Mingming Zhang; Patrick M M Bossuyt; Christina M Vandenbroucke-Grauls
Journal:  Cochrane Database Syst Rev       Date:  2015-12-30

5.  (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.

Authors:  Sandra K White; Robert L Schmidt; Brandon S Walker; Kimberly E Hanson
Journal:  Cochrane Database Syst Rev       Date:  2020-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.